Bacillus Calmette-Guérin (BCG) Treatment Failures in Non-Muscle Invasive Bladder Cancer: What Truly Constitutes Unresponsive Disease

Bacillus Calmette-Guérin (BCG) remains the most effective intravesical therapy for non-muscle invasive bladder cancer but will fail in up to 40% of patients. The ability to identify patients who are least likely to respond to further BCG therapy allows urologists to pursue secondary treatments more...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinberg, Ryan L., Thomas, Lewis J., O’Donnell, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927833/
https://www.ncbi.nlm.nih.gov/pubmed/27376112
http://dx.doi.org/10.3233/BLC-150015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927833/
https://www.ncbi.nlm.nih.gov/pubmed/27376112
http://dx.doi.org/10.3233/BLC-150015

Ejemplares similares